Paul Taylor

Active 1965–2026

330
Papers
42,134
Citations
108
h-index
269
i10-index

Citations

Citations per year for Paul Taylor1965: 1 citations1966: 2 citations1967: 3 citations1968: 4 citations1969: 1 citations1971: 1 citations1973: 1 citations1975: 4 citations1976: 1 citations1979: 1 citations1980: 3 citations1981: 2 citations1982: 5 citations1983: 5 citations1984: 3 citations1985: 7 citations1986: 4 citations1987: 7 citations1988: 7 citations1989: 15 citations1990: 23 citations1991: 50 citations1992: 41 citations1993: 66 citations1994: 77 citations1995: 62 citations1996: 69 citations1997: 90 citations1998: 139 citations1999: 115 citations2000: 164 citations2001: 210 citations2002: 272 citations2003: 432 citations2004: 504 citations2005: 560 citations2006: 609 citations2007: 669 citations2008: 648 citations2009: 610 citations2010: 672 citations2011: 574 citations2012: 528 citations2013: 502 citations2014: 466 citations2015: 459 citations2016: 410 citations2017: 415 citations2018: 398 citations2019: 940 citations2020: 973 citations2021: 779 citations2022: 622 citations2023: 504 citations2024: 721 citations2025: 349 citations2026: 32 citations1970: no citations, so this year is not shown1972: no citations, so this year is not shown1974: no citations, so this year is not shown1977–1978: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,535 citing papers, 25.4% of this breakdownUnited Kingdom: 2,078 citing papers, 11.6% of this breakdownChina: 1,218 citing papers, 6.8% of this breakdownGermany: 926 citing papers, 5.2% of this breakdownFrance: 841 citing papers, 4.7% of this breakdownCanada: 747 citing papers, 4.2% of this breakdownItaly: 652 citing papers, 3.6% of this breakdownAustralia: 619 citing papers, 3.5% of this breakdownJapan: 504 citing papers, 2.8% of this breakdownNetherlands: 455 citing papers, 2.5% of this breakdownIndia: 391 citing papers, 2.2% of this breakdownSpain: 387 citing papers, 2.2% of this breakdown
0%25.4%Other 25.3%

Fields

  • Computer Science31.2%
  • Medicine25.9%
  • Biochemistry, Genetics and Molecular Biology20.8%
  • Psychology4.2%
  • Neuroscience2.5%
  • Environmental Science2%
  • Other13.4%

Topics

  • Speech and dialogue systems3.4%
  • Speech Recognition and Synthesis3.2%
  • Natural Language Processing Techniques3.1%
  • Bioinformatics and Genomic Networks2.6%
  • Logic, programming, and type systems2.6%
  • Birth, Development, and Health2.2%
  • Other82.9%

Coauthors

All papers

Open in search
  1. Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials

    Authors: , , , , , , , , , , , , , , , , , - BMJ 2024 cited by 533

  2. Short-term and long-term effects of caesarean section on the health of women and children

    Authors: , , , , , , , , , , , - The Lancet 2018 cited by 1,379

  3. Dialogue Act Modeling for Automatic Tagging and Recognition of Conversational Speech

    Authors: , , , , , , , , , - Computational Linguistics, Comput. Linguistics 2000 cited by 1,113

  4. Automated Diabetic Retinopathy Image Assessment Software

    Authors: , , , , , , , , , , , , , , , - Ophthalmology 2016 cited by 278

  5. Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2016 cited by 497

  6. EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: a multicentre, open-label, phase 2 study

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2022 cited by 131

  7. Text-to-Speech Synthesis

    Authors: - Cambridge University Press eBooks 2009 cited by 517

  8. The Experience of Work-Related Stress across Occupations

    Authors: , , , , , - Journal of Managerial Psychology 2005 cited by 1,527

  9. Large‐scale mapping of human protein–protein interactions by mass spectrometry

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert Kinach, Sally‐Lin Adams, Michael F. Moran, Gregg B. Morin, Thodoros Topaloglou, Daniel Figeys - Molecular Systems Biology 2007 cited by 1,001

  10. Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hans M. Jespersen, Alexandre V. Podtelejnikov, Eva Møller Nielsen, Janne Crawford, Vibeke Juul Poulsen, Birgitte D. Sørensen, Jesper Matthiesen, Ronald C. Hendrickson, Frank Gleeson, Tony Pawson, Michael F. Moran, Daniel Durocher, Matthias Mann, Christopher W.V. Hogue, Daniel Figeys, Mike Tyers - Nature 2002 cited by 3,627

  11. Diet-Induced Obesity in Female Mice Leads to Offspring Hyperphagia, Adiposity, Hypertension, and Insulin Resistance

    Authors: , , , , , , , , , , , , - Hypertension 2007 cited by 894

  12. Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial

    Authors: , , , , , , , , , , , , , , , , , - The Lancet Oncology 2017 cited by 424

  13. Structure of Ocr from Bacteriophage T7, a Protein that Mimics B-Form DNA

    Authors: , , , , , , , - Molecular Cell 2002 cited by 197

  14. Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND—A Double-Blind, Randomized, Phase II Study

    Authors: , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 cited by 129

  15. Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nicola Steele, K. Franks, P. Nicholas Shaw, Michael Lind, Sunil Upadhyay, Thomas John, Christos S. Karapetis, Ratnesh Kumar Srivastav, Manlio Mencoboni, Antonio Chella, Nicoletta Zilembo, Filippo de Marinis, Maria Giulia Stella, Inn‐Wen Chong, Chin‐Chou Wang - JAMA Oncology 2024 cited by 52

  16. The Evolving Menace of Ransomware: A Comparative Analysis of Pre-pandemic and Mid-pandemic Attacks

    Authors: , , , - Digital Threats Research and Practice, DTRAP 2022 cited by 35

  17. Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elizabeth Fuller, Andrew MacNair, Jonathan Shamash, T. Mansy, Richard Milton, P. Koh, Andreea Alina Ionescu, Sarah Treece, Amy Roy, Gary Middleton, Alan Kirk, Rosie A Harris, Kate Ashton, Barbara Warnes, Emma Bridgeman, Katherine Joyce, Nicola Mills, Daisy Elliott, Nicola Farrar, Elizabeth A Stokes, Vikki Hughes, Andrew G. Nicholson, Chris Rogers - The Lancet Respiratory Medicine 2024 cited by 119

  18. Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2022 cited by 68

  19. An observational study to assess if automated diabetic retinopathy image assessment software can replace one or more steps of manual imaging grading and to determine their cost-effectiveness

    Authors: , , , , , , , , , , , , , , - Health Technology Assessment 2016 cited by 132

  20. Quantification of Key Retinal Features in Early and Late Age-Related Macular Degeneration Using Deep Learning

    Authors: , , , , , , , , , , , , , , , , , , - American Journal of Ophthalmology 2021 cited by 62

  21. Machine Learning Has Arrived!

    Authors: , , , - Ophthalmology 2017 cited by 129

  22. Mesothelioma and Radical Surgery 2 (MARS 2): protocol for a multicentre randomised trial comparing (extended) pleurectomy decortication versus no (extended) pleurectomy decortication for patients with malignant pleural mesothelioma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Barbara Warnes, Nicola Mills, Elizabeth A Stokes, Chris Rogers - BMJ Open 2020 cited by 80

  23. Arginine Deprivation With Pegylated Arginine Deiminase in Patients With Argininosuccinate Synthetase 1–Deficient Malignant Pleural Mesothelioma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dean A. Fennell, Allan Hackshaw - JAMA Oncology 2016 cited by 202

  24. Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2019 cited by 167